Invention Grant
US08748453B2 Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
有权
取代的杂环化合物作为激酶抑制剂及其使用方法
- Patent Title: Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
- Patent Title (中): 取代的杂环化合物作为激酶抑制剂及其使用方法
-
Application No.: US13380693Application Date: 2010-06-24
-
Publication No.: US08748453B2Publication Date: 2014-06-10
- Inventor: Dawei Zhang
- Applicant: Dawei Zhang
- Applicant Address: HK Admiralty
- Assignee: Medolution Limited
- Current Assignee: Medolution Limited
- Current Assignee Address: HK Admiralty
- Agent Feng Tian
- International Application: PCT/US2010/039877 WO 20100624
- International Announcement: WO2010/151710 WO 20101229
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D215/00
Abstract:
The present invention is directed to novel quinolines and quniazolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R1 to R11 and X are defined herein.
Public/Granted literature
- US20120101116A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AS KINASES INHIBITORS AND METHODS OF USE THEREOF Public/Granted day:2012-04-26
Information query
IPC分类:
